Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
7.85
Dollar change
+2.23
Percentage change
39.68
%
IndexRUT P/E- EPS (ttm)-1.34 Insider Own29.81% Shs Outstand139.25M Perf Week50.10%
Market Cap1.10B Forward P/E- EPS next Y-0.11 Insider Trans0.33% Shs Float98.59M Perf Month49.52%
Income-180.91M PEG- EPS next Q-0.04 Inst Own66.02% Short Float12.22% Perf Quarter24.60%
Sales540.28M P/S2.04 EPS this Y18.56% Inst Trans1.45% Short Ratio4.87 Perf Half Y-40.58%
Book/sh0.12 P/B65.61 EPS next Y73.22% ROA-25.90% Short Interest12.04M Perf Year-14.49%
Cash/sh0.71 P/C11.04 EPS next 5Y12.00% ROE-1000.48% 52W Range4.88 - 17.34 Perf YTD-48.05%
Dividend Est.- P/FCF- EPS past 5Y-5.07% ROI-30.81% 52W High-54.73% Beta1.37
Dividend TTM- Quick Ratio1.21 Sales past 5Y40.20% Gross Margin56.76% 52W Low60.86% ATR (14)0.51
Dividend Ex-Date- Current Ratio2.22 EPS Y/Y TTM11.14% Oper. Margin-26.21% RSI (14)78.74 Volatility9.25% 6.33%
Employees839 Debt/Eq13.65 Sales Y/Y TTM28.09% Profit Margin-33.48% Recom1.25 Target Price16.62
Option/ShortYes / Yes LT Debt/Eq13.42 EPS Q/Q34.13% Payout- Rel Volume6.69 Prev Close5.62
Sales Surprise2.40% EPS Surprise-1.22% Sales Q/Q24.51% EarningsOct 30 AMC Avg Volume2.47M Price7.85
SMA2042.65% SMA5036.57% SMA200-25.01% Trades Volume16,529,817 Change39.68%
Date Action Analyst Rating Change Price Target Change
Aug-01-24Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-08-24Initiated Barclays Overweight $19
Feb-09-24Initiated Wells Fargo Overweight $26
Dec-19-23Reiterated Needham Buy $16 → $18
Oct-20-23Initiated ROTH MKM Buy $22
Oct-12-22Initiated Jefferies Buy $12
Sep-12-22Initiated Morgan Stanley Overweight $13
Dec-03-21Initiated Goldman Neutral $12.50
Oct-29-21Initiated Loop Capital Buy $22
Aug-25-21Initiated Needham Buy $18
Today 03:20AM
Oct-30-24 05:10PM
04:06PM
04:00PM
Oct-07-24 09:00AM
09:00AM Loading…
Sep-18-24 09:00AM
Aug-22-24 01:01AM
Aug-05-24 05:01PM
05:01PM
Jul-31-24 05:15PM
04:09PM
04:00PM
Jul-29-24 09:00AM
Jul-24-24 09:00AM
Jul-10-24 09:00AM
09:00AM Loading…
Jun-10-24 09:00AM
May-08-24 01:07PM
May-07-24 09:56PM
06:00PM
04:43PM
04:00PM
May-02-24 09:00AM
Apr-26-24 07:00PM
04:41PM
Apr-17-24 09:00AM
Mar-10-24 03:24PM
Mar-08-24 11:54PM
Mar-04-24 11:52PM
Mar-01-24 12:40AM
Feb-28-24 10:14AM
04:58PM Loading…
Feb-27-24 04:58PM
04:52PM
04:01PM
Jan-29-24 09:00AM
Jan-08-24 09:00AM
08:00AM
Dec-19-23 09:00AM
Nov-07-23 10:52AM
Nov-06-23 04:43PM
04:39PM
04:05PM
Nov-01-23 09:00AM
Oct-31-23 09:00AM
Oct-27-23 04:05PM
Oct-25-23 05:38PM
Oct-24-23 10:59PM
04:01PM
Oct-23-23 07:00AM
Oct-17-23 04:05PM
09:00AM
Oct-16-23 04:05PM
09:00AM
Oct-09-23 04:05PM
Oct-05-23 12:37PM
Sep-18-23 12:14PM
Sep-14-23 01:12PM
Sep-08-23 07:36PM
01:05PM
Aug-07-23 11:00AM
Aug-03-23 04:11PM
04:00PM
Jul-24-23 09:00AM
Jul-18-23 09:00AM
Jul-02-23 09:37AM
Jun-27-23 04:16PM
Jun-06-23 07:00AM
Jun-04-23 10:47AM
May-23-23 09:00AM
May-04-23 04:53PM
04:05PM
10:42AM
Apr-19-23 05:00PM
04:07PM
04:05PM
Apr-17-23 08:24AM
Apr-13-23 09:00AM
Apr-04-23 09:00AM
Mar-13-23 09:39AM
Mar-03-23 08:10PM
Feb-28-23 07:25PM
04:05PM
Feb-21-23 09:00AM
Feb-10-23 08:40AM
Feb-07-23 09:00AM
Jan-09-23 09:00AM
Jan-08-23 09:10AM
Dec-28-22 09:00AM
Dec-12-22 12:32PM
Nov-09-22 06:22AM
Nov-03-22 06:45PM
04:05PM
06:36AM
Nov-01-22 10:01AM
09:00AM
Oct-27-22 10:02AM
Oct-17-22 12:41PM
Oct-12-22 09:00AM
Oct-11-22 09:00AM
Oct-10-22 09:00AM
Oct-05-22 09:55AM
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bakst EvanDirectorAug 23 '24Buy5.7635,000201,60050,000Aug 26 04:32 PM
Pelizzon David RDirectorAug 23 '24Buy5.8916,978100,000331,696Aug 26 04:27 PM
Pelizzon David RDirectorAug 22 '24Buy5.678,81849,998314,718Aug 26 04:27 PM
Demski David MDirectorAug 21 '24Buy5.6750,000283,500288,441Aug 21 10:00 PM
Lish ScottCHIEF OPERATING OFFICERAug 06 '24Option Exercise2.8071,500199,925580,861Aug 08 05:29 PM
Demski David MDirectorAug 02 '24Buy6.5640,000262,400238,441Aug 05 02:49 PM
Valentine KeithDirectorAug 02 '24Buy6.5539,000255,45082,140Aug 05 02:48 PM
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.Jun 12 '24Sale10.8850,232546,524245,638Jun 14 04:30 PM
Koning John ToddCHIEF FINANCIAL OFFICERApr 24 '24Sale12.8237,500480,750393,356Apr 26 04:38 PM
Bakst EvanDirectorMar 14 '24Buy13.5315,000202,95015,000Mar 18 11:35 AM
Blackford Quentin S.DirectorMar 07 '24Buy12.8320,000256,600572,605Mar 08 08:55 PM
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.Mar 06 '24Sale13.169,225121,401295,870Mar 08 05:30 PM
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.Mar 01 '24Sale13.3011,825157,272305,095Mar 04 08:45 PM
Koning John ToddCHIEF FINANCIAL OFFICERMar 01 '24Sale13.30121,6011,617,293430,856Mar 04 08:43 PM
Sponsel DavidEVP, SALESFeb 27 '24Sale15.1932,365491,624622,296Feb 29 06:51 PM
Lish ScottCHIEF OPERATING OFFICERFeb 27 '24Sale15.1931,075472,029507,165Feb 29 06:49 PM
Hunsaker Craig EEVP, PEOPLE & CULTUREFeb 26 '24Sale15.0541,560625,4781,188,444Feb 28 12:21 PM
Sponsel DavidEVP, SALESFeb 21 '24Sale15.3417,820273,359654,661Feb 22 06:31 PM
Hunsaker Craig EEVP, PEOPLE & CULTUREFeb 20 '24Sale15.1677,2551,171,1861,188,814Feb 22 06:31 PM
Lish ScottCHIEF OPERATING OFFICERFeb 21 '24Sale15.3411,963183,512538,240Feb 22 06:30 PM
Sponsel DavidEVP, SALESFeb 14 '24Sale16.162,50040,400637,418Feb 15 05:49 PM
Sponsel DavidEVP, SALESFeb 02 '24Sale16.4736,620603,131639,918Feb 05 06:48 PM
Hunsaker Craig EEVP, PEOPLE & CULTUREFeb 02 '24Sale16.5138,556636,5601,266,569Feb 05 06:46 PM
Hunsaker Craig EEVP, PEOPLE & CULTUREFeb 05 '24Sale16.415008,2051,266,069Feb 05 06:46 PM
Lish ScottCHIEF OPERATING OFFICERFeb 02 '24Sale16.4725,210415,209518,457Feb 05 06:44 PM
Sponsel DavidEVP, SALESJan 16 '24Sale15.002,50037,500555,280Jan 17 04:30 PM
Sponsel DavidEVP, SALESDec 21 '23Sale15.002,50037,500557,780Dec 26 07:25 PM
Demski David MDirectorNov 09 '23Buy10.5030,000315,000181,694Nov 13 10:19 AM
Last Close
Oct 31 04:00PM ET
2.43
Dollar change
-0.08
Percentage change
-3.19
%
XGN Exagen Inc daily Stock Chart
Index- P/E- EPS (ttm)-0.97 Insider Own52.63% Shs Outstand17.05M Perf Week-14.44%
Market Cap42.25M Forward P/E- EPS next Y-0.83 Insider Trans0.44% Shs Float8.24M Perf Month-15.33%
Income-17.31M PEG- EPS next Q-0.29 Inst Own36.38% Short Float0.28% Perf Quarter19.12%
Sales56.66M P/S0.75 EPS this Y28.44% Inst Trans2.50% Short Ratio0.45 Perf Half Y75.45%
Book/sh1.01 P/B2.40 EPS next Y13.02% ROA-30.51% Short Interest0.02M Perf Year42.11%
Cash/sh1.41 P/C1.73 EPS next 5Y- ROE-69.97% 52W Range1.30 - 3.71 Perf YTD22.11%
Dividend Est.- P/FCF- EPS past 5Y2.69% ROI-43.68% 52W High-34.50% Beta1.33
Dividend TTM- Quick Ratio4.01 Sales past 5Y10.63% Gross Margin59.13% 52W Low86.88% ATR (14)0.17
Dividend Ex-Date- Current Ratio4.32 EPS Y/Y TTM52.30% Oper. Margin-27.90% RSI (14)35.00 Volatility6.27% 5.98%
Employees179 Debt/Eq1.36 Sales Y/Y TTM7.05% Profit Margin-30.56% Recom1.33 Target Price6.25
Option/ShortYes / Yes LT Debt/Eq1.25 EPS Q/Q42.51% Payout- Rel Volume0.40 Prev Close2.51
Sales Surprise14.76% EPS Surprise52.94% Sales Q/Q6.56% EarningsAug 05 BMO Avg Volume52.40K Price2.43
SMA20-11.00% SMA50-16.02% SMA20012.45% Trades Volume20,710 Change-3.19%
Date Action Analyst Rating Change Price Target Change
Aug-05-22Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-15-21Resumed Cowen Outperform $26
Apr-15-21Initiated Canaccord Genuity Buy $25
Nov-10-20Initiated KeyBanc Capital Markets Overweight $32
Oct-08-20Initiated BTIG Research Buy $18
Jun-02-20Resumed Cantor Fitzgerald Overweight $19 → $20
Oct-14-19Initiated William Blair Outperform
Oct-14-19Initiated Cowen Outperform $17
Oct-14-19Initiated Cantor Fitzgerald Overweight $18
Oct-29-24 04:05PM
Oct-21-24 04:05PM
Sep-04-24 04:05PM
Aug-29-24 09:55AM
Aug-26-24 08:50AM
09:15AM Loading…
Aug-09-24 09:15AM
Aug-08-24 08:50AM
Aug-05-24 12:53PM
09:10AM
08:00AM
Aug-02-24 09:00AM
Aug-01-24 09:00AM
Jul-22-24 09:00AM
Jun-13-24 08:50AM
May-15-24 05:01AM
12:53PM Loading…
May-13-24 12:53PM
09:10AM
08:00AM
May-06-24 04:05PM
Apr-30-24 04:05PM
Apr-26-24 08:30AM
Mar-19-24 09:37AM
01:55AM
Mar-18-24 12:52PM
09:25AM
08:00AM
Mar-08-24 09:00AM
Mar-07-24 04:05PM
Feb-06-24 08:50AM
Jan-30-24 04:05PM
12:00PM Loading…
Jan-07-24 12:00PM
Nov-13-23 04:05PM
Nov-09-23 04:05PM
Nov-02-23 04:05PM
Oct-30-23 04:05PM
Sep-28-23 04:05PM
Sep-12-23 04:05PM
Aug-09-23 10:47AM
Aug-08-23 04:13AM
Aug-07-23 09:15AM
08:00AM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-24-23 04:05PM
07:33AM
Jun-13-23 08:19AM
May-30-23 09:00AM
May-17-23 07:11AM
May-16-23 11:03AM
May-15-23 05:55PM
04:05PM
May-01-23 04:05PM
Apr-24-23 04:05PM
Mar-24-23 08:16AM
Mar-22-23 06:12AM
Mar-21-23 07:40AM
Mar-20-23 05:25PM
04:05PM
Mar-06-23 04:05PM
Feb-27-23 09:00AM
Feb-14-23 06:19AM
Jan-30-23 04:05PM
Jan-23-23 09:00AM
Nov-14-22 07:55PM
04:05PM
Nov-08-22 04:05PM
Oct-31-22 04:05PM
Oct-17-22 09:00AM
Oct-04-22 08:25AM
Sep-20-22 04:05PM
Sep-19-22 10:20AM
Sep-01-22 04:05PM
Aug-05-22 12:00PM
Aug-04-22 06:55PM
04:06PM
04:05PM
Jul-25-22 04:05PM
Jul-21-22 04:05PM
Jul-05-22 08:25AM
Jun-21-22 08:10AM
Jun-09-22 08:25AM
May-26-22 04:05PM
May-16-22 04:05PM
May-11-22 05:55PM
04:06PM
04:05PM
May-10-22 10:45AM
May-03-22 05:15PM
May-01-22 12:00PM
Apr-25-22 04:05PM
Apr-20-22 04:05PM
Apr-12-22 07:22AM
Mar-30-22 08:25AM
Mar-22-22 10:00PM
05:25PM
04:06PM
04:05PM
Mar-16-22 04:05PM
Mar-09-22 05:35PM
04:05PM
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adawi KamalOfficerOct 08 '24Proposed Sale2.9484,162247,436Oct 08 04:39 PM
Adawi KamalOfficerAug 09 '24Proposed Sale2.7652,624145,242Aug 09 05:08 PM
ABALLI JOHNPresident and CEOMay 16 '24Buy1.9240,40177,57040,401May 16 08:02 PM
Adawi KamalCFO and Corporate SecretaryMar 04 '24Sale1.9112,78424,407243,749Mar 06 04:05 PM
Adawi KamalCFO and Corporate SecretaryFeb 06 '24Sale1.956,73813,133181,533Feb 08 04:05 PM